Review
Oral hypoglycemic drugs and cardiovascular pathology
- PMID: 382336
Item in Clipboard
Review
Oral hypoglycemic drugs and cardiovascular pathology
Med Interne.
1979 Apr-Jun.
Abstract
The classification, the mechanisms of action and the main side effects of sulfonylureic derivatives and biguanides are discussed. Emphasis is laid on the present controversy concerning the assumed adverse effect of these drugs on the cardiovascular system. The authors' opinion in this problem and their practical conclusions are based on their experience at the Center of Nutrition and Metabolic Diseases, Bucharest.
Similar articles
-
Oral hypoglycaemic agents--dangers and contraindications.Med J Aust. 1976 Oct 16;2(16):605, 608-9. Med J Aust. 1976. PMID: 1004309 No abstract available.
-
[Long term efficacy and tolerance of antidiabetic treatments. New data].Nouv Presse Med. 1974 Jun 15;3(24):1551-4. Nouv Presse Med. 1974. PMID: 4211493 French. No abstract available.
-
[Differential therapy using oral antidiabetics].Internist (Berl). 1971 Nov;12(11):468-75. Internist (Berl). 1971. PMID: 4943878 German. No abstract available.
-
[25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available.
-
Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.Herz. 2004 May;29(3):290-8. doi: 10.1007/s00059-004-2476-5. Herz. 2004. PMID: 15167955 Review.